Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX ; volume:9 ; number:1 ; day:14 ; month:9 ; year:2011 ; pages:1 ; date:12.2011
Pediatric rheumatology ; 9, Heft 1 (14.9.2011), 1, 12.2011
- Creator
-
Verkaaik, M.
Bulatović, M.
Sinnema, G.
Rademaker, C.
Wulffraat, NM
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-9-S1-O23
- URN
-
urn:nbn:de:101:1-2021082421160334413087
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Verkaaik, M.
- Bulatović, M.
- Sinnema, G.
- Rademaker, C.
- Wulffraat, NM
- SpringerLink (Online service)
Other Objects (12)
Methotrexate intolerance in Rheumatoid Arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Validation of Methotrexate Intolerance Severity Score (MISS) questionnaire to measure methotrexate intolerance among rheumatoid arthritis Egyptian patients
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study